PTX-COVID19-B

N/A

Report date: 2026/05/13 11:18:05

Base Information

Drug NamePTX-COVID19-B
Drug Alias NamePTX-COVID19-B
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaSouth Africa
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesProvidence Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesEverest Medicines (Suzhou) IncChina Resources Pharmaceutical Group LtdEverest Medicines (Singapore) Pte Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A